NO20035399L - Pyrrolidinoksadiazol- og tiadiazolderivater - Google Patents

Pyrrolidinoksadiazol- og tiadiazolderivater

Info

Publication number
NO20035399L
NO20035399L NO20035399A NO20035399A NO20035399L NO 20035399 L NO20035399 L NO 20035399L NO 20035399 A NO20035399 A NO 20035399A NO 20035399 A NO20035399 A NO 20035399A NO 20035399 L NO20035399 L NO 20035399L
Authority
NO
Norway
Prior art keywords
thiadiazole derivatives
pyrrolidine oxadiazole
oxadiazole
pyrrolidine
thiadiazole
Prior art date
Application number
NO20035399A
Other languages
English (en)
Norwegian (no)
Other versions
NO20035399D0 (no
Inventor
Matthias Schwarz
Russel J Thomas
Anna Quattorpani
Patrick Page
Vincent Pomel
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of NO20035399D0 publication Critical patent/NO20035399D0/no
Publication of NO20035399L publication Critical patent/NO20035399L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/06Antiabortive agents; Labour repressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
NO20035399A 2001-06-18 2003-12-04 Pyrrolidinoksadiazol- og tiadiazolderivater NO20035399L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01113632 2001-06-18
PCT/EP2002/006629 WO2002102799A2 (en) 2001-06-18 2002-06-14 Pyrrolidine oxadiazole- and thiadiazole oxime derivatives being oxytocin receptor antagonists

Publications (2)

Publication Number Publication Date
NO20035399D0 NO20035399D0 (no) 2003-12-04
NO20035399L true NO20035399L (no) 2004-02-17

Family

ID=8177641

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20035399A NO20035399L (no) 2001-06-18 2003-12-04 Pyrrolidinoksadiazol- og tiadiazolderivater

Country Status (27)

Country Link
US (2) US7115639B2 (cs)
EP (1) EP1444225B1 (cs)
JP (1) JP4426284B2 (cs)
KR (1) KR20040030678A (cs)
CN (1) CN100564378C (cs)
AR (1) AR036108A1 (cs)
AU (1) AU2002319237B2 (cs)
BG (1) BG108424A (cs)
BR (1) BR0211030A (cs)
CA (1) CA2449578C (cs)
CZ (1) CZ20033475A3 (cs)
EA (1) EA006212B1 (cs)
EE (1) EE200400022A (cs)
ES (1) ES2397305T3 (cs)
HK (1) HK1074204A1 (cs)
HR (1) HRP20031017A2 (cs)
HU (1) HUP0400238A2 (cs)
IL (1) IL159219A0 (cs)
MX (1) MXPA03011441A (cs)
MY (1) MY128890A (cs)
NO (1) NO20035399L (cs)
PL (1) PL367275A1 (cs)
RS (1) RS99503A (cs)
SK (1) SK15552003A3 (cs)
UA (1) UA75145C2 (cs)
WO (1) WO2002102799A2 (cs)
ZA (1) ZA200309402B (cs)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA006212B1 (ru) 2001-06-18 2005-10-27 Апплайд Резеч Системз Арс Холдинг Н.В. Оксадиазольные и тиадиазольные производные пирролидина
US7557136B2 (en) 2003-02-27 2009-07-07 Laboratoires Serono Sa Pyrrolidine derivatives as oxytocin antagonists
BRPI0508059A (pt) * 2004-02-26 2007-07-17 Applied Research Systems método para preparação de pirrolidina oximas
RS54876B1 (sr) 2005-05-10 2016-10-31 Incyte Holdings Corp Modulatori indoleamina 2,3-dioksigenaze i metode za upotrebu istih
JP5294874B2 (ja) 2005-12-20 2013-09-18 インサイト・コーポレイション インドールアミン2,3−ジオキシゲナーゼのモジュレーターとしてのn−ヒドロキシアミジノヘテロ環
CL2007002650A1 (es) 2006-09-19 2008-02-08 Incyte Corp Compuestos derivados de heterociclo n-hidroxiamino; composicion farmaceutica, util para tratar cancer, infecciones virales y desordenes neurodegenerativos entre otras.
US20080125470A1 (en) * 2006-09-19 2008-05-29 Incyte Corporation N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
MY171866A (en) 2008-07-08 2019-11-05 Incyte Holdings Corp 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase
EP2845850A1 (en) 2013-09-10 2015-03-11 ObsEva S.A. Pyrrolidine derivatives as oxytocin/vasopressin V1a receptors antagonists
BR112016009786B1 (pt) 2013-11-08 2021-01-05 Incyte Holdings Corporation compostos inibidores de indoleamina 2,3-dioxigenase e seus processos de síntese
EP2886107A1 (en) 2013-12-17 2015-06-24 ObsEva S.A. Oral formulations of pyrrolydine derivatives
JP2017519015A (ja) 2014-07-02 2017-07-13 オブセヴァ エス.エー. Ot−r活性に関する疾患を治療するための方法に有用な結晶質の(3z,5s)−5−(ヒドロキシメチル)−1−[(2’−メチル−1,1’−ビフェニル−4−イル)カルボニル]ピロリジン−3−オン о−メチルオキシム

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2722190B1 (fr) * 1994-07-05 1996-10-04 Sanofi Sa Derives de 1-benzyl-1,3-dihydro-2h-benzimidazol-2-one, leur preparation, les compositions pharmaceutique en contenant
EP0805681A4 (en) 1995-01-24 1998-05-06 Merck & Co Inc TOCOLYTIC ANTAGONISTS OF OXYTOCIN RECEPTORS
US5756497A (en) 1996-03-01 1998-05-26 Merck & Co., Inc. Tocolytic oxytocin receptor antagonists
FR2757157B1 (fr) 1996-12-13 1999-12-31 Sanofi Sa Derives d'indolin-2-one, procede pour leur preparation et compositions pharmaceutiques les contenant
DE60026514T2 (de) 1999-05-05 2006-11-09 Merck & Co., Inc. Neue prolinverbindungen als mikrobizide mittel
SI1268418T1 (sl) * 2000-03-27 2006-10-31 Applied Research Systems Farmacevtsko aktivni pirolidinski derivati kot bax-inhibitorji
ES2261404T3 (es) * 2000-03-27 2006-11-16 Applied Research Systems Ars Holding N.V. Derivados de pirrolidina utiles como inhibidores de bax.
EP1335901B1 (en) * 2000-10-17 2010-04-14 Merck Serono SA Pharmaceutically active sulfanilide derivatives
JP4350948B2 (ja) * 2001-03-20 2009-10-28 ラボラトワール セローノ ソシエテ アノニム オキシトシン調節活性を有するピロリジンエステル誘導体
EA006212B1 (ru) 2001-06-18 2005-10-27 Апплайд Резеч Системз Арс Холдинг Н.В. Оксадиазольные и тиадиазольные производные пирролидина
JP4511184B2 (ja) * 2001-12-20 2010-07-28 メルク セローノ ソシエテ アノニム オキシトシン・アンタゴニストとしてのトリアゾール類
UA78058C2 (en) * 2002-07-05 2007-02-15 Applied Research Systems Pyrrolidine derivative as oxitocin antagonists

Also Published As

Publication number Publication date
KR20040030678A (ko) 2004-04-09
CA2449578C (en) 2011-12-13
PL367275A1 (en) 2005-02-21
RS99503A (en) 2006-12-15
SK15552003A3 (sk) 2004-05-04
AU2002319237B2 (en) 2008-01-03
EP1444225A2 (en) 2004-08-11
BG108424A (en) 2005-03-31
EE200400022A (et) 2004-04-15
US20060229343A1 (en) 2006-10-12
HK1074204A1 (en) 2005-11-04
CN100564378C (zh) 2009-12-02
IL159219A0 (en) 2004-06-01
BR0211030A (pt) 2004-06-22
ES2397305T3 (es) 2013-03-06
CN1639155A (zh) 2005-07-13
US20040220238A1 (en) 2004-11-04
US7115639B2 (en) 2006-10-03
HRP20031017A2 (en) 2004-04-30
MY128890A (en) 2007-02-28
MXPA03011441A (es) 2004-07-01
CZ20033475A3 (en) 2004-05-12
JP4426284B2 (ja) 2010-03-03
CA2449578A1 (en) 2002-12-27
EP1444225B1 (en) 2012-10-10
EA200400049A1 (ru) 2004-08-26
NO20035399D0 (no) 2003-12-04
JP2004534804A (ja) 2004-11-18
WO2002102799A2 (en) 2002-12-27
UA75145C2 (en) 2006-03-15
WO2002102799A3 (en) 2003-04-03
AR036108A1 (es) 2004-08-11
HUP0400238A2 (hu) 2004-07-28
EA006212B1 (ru) 2005-10-27
ZA200309402B (en) 2004-12-03

Similar Documents

Publication Publication Date Title
CY2016002I1 (el) Ν-υποκατεστημενο καρβαμουλοξυαλκυλιο - παραγωγα αζολιου
IS6385A (is) Ný notkun og nýjar N-asabísýkló-amíð afleiður
DK1400518T3 (da) Heterocycliske forbindelser og lægemidler
DE50112013D1 (de) Deodorantien und antiperspirantien
DK1292604T3 (da) 2-Aminocarbonyl-9H-purinderivater
ATE319451T1 (de) Tetrahydrochinolin-derivate
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
AR028343A1 (es) Derivados de pirrolidina y piperidina
IS6759A (is) Ný þíadíasól og oxadíasól og notkun þeirra sem fosfórdíesterasa-7 hindra
HK1074204A1 (en) Pyrrolidine oxadiazole-and thiadiazole derivatives
ATE298332T1 (de) Decahydro-isochinolinderivate
DK1280809T3 (da) Antitumorecteinascidinderivater
ATE297920T1 (de) Linezolid-krystall form ii
DK1226131T3 (da) Isoxazolcarboxamidderivater
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
DE60032898D1 (de) Arylthiazolidindion- und aryloxazolidinderivate
DK1322593T3 (da) O-substituerede-6-methyl-tramadol-derivater
EP1392317A4 (en) SUBSTITUTED 1-BENZAZEPINE AND DERIVATIVES THEREOF
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DK1246791T3 (da) Aminomethyl-phenyl-cyklohexanonderivater
ATE299873T1 (de) Substituierte c-furan-2-yl-methylamin- und c- thiophen-2-yl-methylamin-derivate
NO20023675D0 (no) Heterocykliske amidderivater
DE60106740D1 (de) Hydrazid und alkoxyamid angiogeneseinhibitoren
DE60202381D1 (de) Paroxetin-n-formyl-derivate